New DermaPrecise patent application and patents granted for tendinopathy and skin rejuvenation technologies in key marketsVANCOUVER, BC / ACCESSWIRE / August 4, 2022 / RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2)
RepliCel Announces Material Patent Milestones in Key Markets streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Each Unit consists of one common share of the Company (each, a “ Share ”) and one-half of one share purchase warrant (each, a “ Warrant ”). Each whole Warrant entitles the holder thereof to purchase one additional Share of the Company at a price of $0.
RepliCel Announces Material Patent Milestones tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.